Exp Neurobiol.  2013 Mar;22(1):38-44. 10.5607/en.2013.22.1.38.

PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices

Affiliations
  • 1Neuroscience Graduate Program, Ajou University School of Medicine, Suwon 442-721, Korea. ehjoe@ajou.ac.kr
  • 2Department of Pharmacology, Ajou University School of Medicine, Suwon 442-721, Korea.
  • 3Chronic Inflammatory Disease Research Center, Ajou University School of Medicine, Suwon 442-721, Korea.
  • 4National Research Lab of Brain Inflammation, Ajou University School of Medicine, Suwon 442-721, Korea.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative motor disease caused by degeneration of dopaminergic neurons in the substantia nigra. Because brain inflammation has been considered a risk factor for PD, we analyzed whether PTEN induced putative kinase 1 (PINK1), an autosomal recessive familial PD gene, regulates brain inflammation during injury states. Using acutely prepared cortical slices to mimic injury, we analyzed expression of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin (IL)-1beta, and IL-6 at the mRNA and protein levels. Both mRNA and protein expression of these cytokines was higher at 6-24 h after slicing in PINK1 knockout (KO) slices compared to that in wild-type (WT) slices. In serial experiments to understand the signaling pathways that increase inflammatory responses in KO slices, we found that IkappaB degradation was enhanced but Akt phosphorylation decreased in KO slices compared to those in WT slices. In further experiments, an inhibitor of PI3K (LY294002) upstream of Akt increased expression of pro-inflammatory cytokines. Taken together, these results suggest that PINK1 deficiency enhance brain inflammation through reduced Akt activation and enhanced IkappaB degradation in response to brain injury.

Keyword

Parkinson's disease; PINK1; inflammation

MeSH Terms

Brain
Brain Injuries
Cytokines
Dopaminergic Neurons
Encephalitis
Hydrazines
Inflammation
Interleukin-6
Interleukins
Parkinson Disease
Phosphorylation
Phosphotransferases
Risk Factors
RNA, Messenger
Substantia Nigra
Tumor Necrosis Factor-alpha
Cytokines
Hydrazines
Interleukin-6
Interleukins
Phosphotransferases
RNA, Messenger
Tumor Necrosis Factor-alpha
Full Text Links
  • EN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr